EMERYVILLE, Calif. - Metagenomi Therapeutics, Inc. (NASDAQ:MGX) has completed a corporate name change from Metagenomi, Inc. as part of a strategic shift to focus on later-stage preclinical assets, the ...
see more of our stories on Google. Add Axios on Google From left, former LabCentral CEO Johannes Fruehauf and current CEO Maggie O'Toole. Photo: Lane Turner/The Boston Globe via Getty Images ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results